Peptic Ulcer Testing - Global Strategic Business Report 2015-2022 - Sustained increase in Prevalence of Infectious Diseases Turns Focus onto Rapid Testing - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Peptic
Ulcer Testing - Global Strategic Business Report"
report to
their offering.


The report provides separate comprehensive analytics for the US, Japan,
Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates
and forecasts are provided for the period 2015 through 2022. Also, a
six-year historic analysis is provided for these markets. Market data
and analytics are derived from primary and secondary research. This
report analyzes the worldwide markets for Peptic Ulcer Testing in US$
Thousand.

Companies Profiled:

  • Becton, Dickinson and Company (US)
  • Beckman Coulter, Inc. (US)
  • Biomerica, Inc. (US)
  • Biohit Oyj (Finland)
  • bioMérieux SA (France)
  • Bio-Rad Laboratories, Inc. (US)
  • DiaSorin S.p.A. (Italy)
  • EKF Diagnostics (UK)
  • Exalenz Bioscience Ltd. (Israel)
  • Halyard Health, Inc. (US)
  • Kibion AB (Sweden)
  • Meridian Bioscience, Inc. (US)
  • Otsuka America Pharmaceutical, Inc. (US)
  • Orion Diagnostica Oy (Finland)
  • Polymedco CDP, LLC (US)
  • Quidel Corporation (US)
  • Sekisui Diagnostics, LLC (US)
  • Thermo Fisher Scientific, Inc. (US)

Key Topics Covered:

1. MARKET OVERVIEW

2. MARKET TRENDS & ISSUES

Sustained increase in Prevalence of Infectious Diseases Turns Focus onto
Rapid Testing

Higher Risk of H. pylori Disease Raises Demand for Testing from Elderly
Population

Differential Accuracy of Diagnostic Tests in Adults and Children

Rapid Tests - Enabling Faster Testing for H. Pylori Infection

Rapid Urease Tests: Most Useful Invasive Test for H. Pylori Detection

Urea Breath Test - A Gold Standard in Non-Invasive Tests

Availability of Tests Influences Market Adoption

Cost Influencing Choice of Testing for H. Pylori

Recommendations for H. Pylori Diagnostic Tests - An Overview

Diagnostic Methods for H. Pylori Infection as Recommended by Guidelines
in Select Countries

Histology, UBT and SAT: Expensive Yet High-Value Offering Tests

DVC-FISH Test Offers Positive Results in Detecting Viable H. Pylori
Cells in Fecal Samples

FIVH (fluorescence in vivo hybridization) - The New Kid on the Block

Guidelines for Diagnosing H. Pylori Ulcers in Children

Antibody Tests Not Recommended for Children; Biopsy Tests More Pertinent

3. PEPTIC ULCERS - THE DISEASE, CAUSES, SYMPTOMS, TYPES, DIAGNOSIS, AND
TREATMENT

4. PEPTIC ULCER DIAGNOSIS AND TESTS

5. PRODUCTS INNOVATIONS/INTRODUCTIONS

6. RECENT INDUSTRY ACTIVITY

7. FOCUS ON SELECT GLOBAL PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 41 (including Divisions/Subsidiaries - 46)

- The United States (26)

- Canada (1)

- Europe (16)

- France (3)

- Germany (1)

- The United Kingdom (3)

- Italy (1)

- Spain (1)

- Rest of Europe (7)

- Asia-Pacific (Excluding Japan) (2)

- Middle East (1)

For more information about this report visit http://www.researchandmarkets.com/research/dqzn35/peptic_ulcer


Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Diagnostics